Is Climb Bio, Inc. (CLYM) a Buy, Sell, or Hold?
NASDAQ : CLYM
Climb Bio, Inc. — Competitors
$12.79 USD
-$0.05 (-0.39%)
- Volume
- 1.21M
- Average Volume
- 1.25M
- Market Capitalization
- $872.08M
- P/E Ratio
- -16.40
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $14.42
- Year Low
- $1.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.86
CLYM vs. The Competition
| Properties | CLYM | ABOS | ACTU | AGEN |
|---|---|---|---|---|
| Market Cap | $872.08M | $158.9M | $27.51M | $255.27M |
| Shares Outstanding | $68.18M | $72.23M | $23.93M | $41.64M |
| P/E Ratio | -16.4 | -1.18 | -1.16 | 3.54 |
| EPS | -0.77 | -1.79 | -0.92 | 1.7 |
| Day Low | 12.37 | 2.175 | 1.11 | 5.87 |
| Day High | 14.36 | 2.25 | 1.21 | 6.2 |
| Year Low | 1.36 | 1.19 | 1.11 | 2.71 |
| Year High | 14.415 | 3.6 | 9.22 | 8.7 |
| Average Price 50 | 11.9767 | 2.3914 | 1.8667 | 3.7354 |
| Average Price 200 | 6.80733 | 2.34963 | 4.16245 | 3.7164 |
| Volume | 1.21M | 241.81K | 224.53K | 1.23M |
| Average Volume | - | - | - | - |